Tech Company Financing Transactions

T2 Biosystems Funding Round

Goldman Sachs, Aisling Capital and Arcus Ventures participated in a $40 million Series E venture round for T2 Biosystems. This venture round was announced on 3/28/2013.

Transaction Overview

Company Name
T2 Biosystems
Announced On
3/28/2013
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series E
Investors

Goldman Sachs (Lead Investor)

Aisling Capital (Jjosh Bilenker)

Arcus Ventures

Camros Capital

Flagship Pioneering (Harry Wilcox)

Flybridge Capital Partners (Michael Greeley)

Partners HealthCare System

Physic Ventures (Stacy Feld)

Polaris Partners (Alan Crane)

WS Investment

Proceeds Purpose
The Company also intends to use the proceeds to complete development of additional sepsis diagnostic panels and to advance and expand its research and development of other molecular, immunodiagnostic and hemostasis assays.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
101 Hartwell Ave.
Lexington, MA 02421
USA
Phone
(781) 457-1200
Website
www.t2biosystems.com
Email Address
[email protected]
Overview
T2 Biosystems (NASDAQ: TTOO) is a diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital.
Profile
T2 Biosystems LinkedIn Company Profile
Social Media
T2 Biosystems Company Twitter Account
Company News
T2 Biosystems News
Facebook
T2 Biosystems on Facebook
YouTube
T2 Biosystems on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John McDonough
  John McDonough LinkedIn Profile  John McDonough Twitter Account  John McDonough News  John McDonough on Facebook
Chief Financial Officer
John Sprague
  John Sprague LinkedIn Profile  John Sprague Twitter Account  John Sprague News  John Sprague on Facebook
Chief Scientific Officer
Thomas Lowery
  Thomas Lowery LinkedIn Profile  Thomas Lowery Twitter Account  Thomas Lowery News  Thomas Lowery on Facebook
VP - General Counsel
Michael Gibbs
  Michael Gibbs LinkedIn Profile  Michael Gibbs Twitter Account  Michael Gibbs News  Michael Gibbs on Facebook
VP - Human Resources
Kelley Morgan
  Kelley Morgan LinkedIn Profile  Kelley Morgan Twitter Account  Kelley Morgan News  Kelley Morgan on Facebook
VP - Operations
Alec Barclay
  Alec Barclay LinkedIn Profile  Alec Barclay Twitter Account  Alec Barclay News  Alec Barclay on Facebook
VP - Regulatory Affairs
Sandy Estrada
  Sandy Estrada LinkedIn Profile  Sandy Estrada Twitter Account  Sandy Estrada News  Sandy Estrada on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/28/2013: Q2 Holdings venture capital transaction
Next: 3/28/2013: CumuLogic venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.